Herpes zoster ophthalmicus infection after kidney transplantation

Year 2020, , 48 - 50, 29.04.2020

Cihan Semet , Seray Türe Suat Akgür , Abdulmecit Yildiz , Alparslan Ersoy

https://doi.org/10.46310/tjim.691092

Abstract

Herpes zoster causes an acute dermatomal infection with vesicular rash associated with reactivation of the Varicella zoster virus. The infection usually involves the thoracic, cervical, ophthalmic and lumbosacral regions. Herpes zoster infection is common after solid organ transplantation. Herpes zoster ophthalmicus is a rare form of Herpes zoster infection and involves the ophthalmic branch of the trigeminal nerve along the V1-V2 dermatomes. Herein, we reported a kidney recipient who developed Herpes zoster ophthalmicus infection after transplantation.

Keywords

Herpes zoster, kidney transplantation, infection

References

• 1. Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8.
• 2. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis. 2008 Jul;10(4):260-8.
• 3. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008 Feb;115(2 Suppl):S3-12. doi: 10.1016/j.ophtha.2007.10.009.
• 4. Pavan-Langston D. Herpes zoster ophthalmicus. Neurology. 1995 Dec;45(12 Suppl 8):S50-1.
• 5. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982 Sep;61(5):310-6.
• 6. Mary A Albrecht MA, Levin MJ. Epidemiology, clinical manifestations, and diagnosis of herpes zoster. In: Hirsch MS, Mitty J, editors. UpToDate [Internet]. Waltham (MA): UpToDate Inc; 2020 [cited 2020 Feb]. Available from: https://www.uptodate.com/contents/ epidemiology-clinical-manifestations-and-diagnosis-of-herpes.
• 7. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007 Nov;82(11):1341-9.
• 8. Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997 Jun 9;157(11):1209-13.
• 9. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004 Jan;4(1):108-15.
• 10. Lauzurica R, Bayés B, Frías C, Fontseré N, Hernandez A, Matas L, Jimenez A, Bonet J, Romero R. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc. 2003 Aug;35(5):1758-9.
• 11. Hong MJ, Kim YD, Cheong YK, Park SJ, Choi SW, Hong HJ. Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. Medicine (Baltimore). 2016 Apr;95(14):e3304. doi: 10.1097/MD.0000000000003304.
• 12. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002 Jul 4;347(1):26-34.
• 13. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007 Mar 29;356(13):1338-43.
• 14. Ostermann ME, Gyawali P, Snowden SA, Eastwood JB, Streather CP. A 67-year-old kidney transplant patient with headache of uncertain origin. Nephrol Dial Transplant. 2002 Mar;17(3):508-10.